logo
Market icon
Coronavirus

Will there be an Emergency Use Authorization (EUA) granted for a COVID-19 vaccine prior to Nov 3 2020?

Expiration

Exp.

November 4, 2020

 

Volume

Vol.

$21,436.67

 

Liquidity

Liq.

$2,000.00


1H
6H
1D
1W
1M
ALL

About this market

Latest News

  • Emergency Use Authorization for Covid Vaccine: One Hurdle of Many

    Who will be the first company to secure an Emergency Use Authorization for a Covid-19 vaccine, and when? This question has circulated in the popular press for a few months and is at the forefront of many Americans’ minds with the upcoming presidential election on November 3rd.
    Read more

  • Johnson & Johnson’s coronavirus vaccine trial is paused after ‘adverse event’ in a participant

    Johnson & Johnson’s late-stage coronavirus vaccine was paused after a participant reported an “adverse event” about 36 hours earlier, the company’s chief financial officer said Tuesday. The pause will allow the data and safety monitoring board to thoroughly investigate the unexplained illness, CFO Joseph Wolk said in an interview on CNBC’s “Squawk Box.”
    Read more

Resolution Source: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization#covid19euas